Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...
Tags: Gilead, Sofosbuvir NDA
US-based biopharmaceutical company Acadia Pharmaceuticals's glaucoma collaboration partner Allergan has advanced a new additional drug candidate into preclinical development for the treatment of glaucoma. Acadia CEO Uli Hacksell said that ...
Tags: Preclinical Development, Allergan
Research-based biopharmaceutical company AbbVie has announced the availability of new, higher-dose of Creon (pancrelipase) delayed-release capsules in the US. Indicated for patients with exocrine pancreatic insufficiency (EPI), 36,000 ...
Integrated biopharmaceutical company ThromboGenics has announced the launch of Jetrea in Denmark and Sweden by Alcon, a division of Novartis. Alcon expects to roll out the European Commission approved Jetrea, which is indicated for the ...
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax. The patent claims describe methods of preparing an immunologically-active adjuvant-bound, thermostable, ...
Tags: Thermovax Technology, US Patent
Biopharmaceutical company Actinium Pharmaceuticals has received notice of patent allowance for an application covering the treatment of metastatic solid cancers with alpha emitting isotopes. The patent application 'Alpha Emitting ...
Tags: Actinium, Cancer Treatment
Ferring Italy SpA, a biopharmaceutical company, has deployed the Cegedim's cloud-based Mobile Intelligence customer relationship management (CRM) solution. As part of the CRM deployment, Ferring Italy has also deployed Cegedim's OneKey, ...
Suven Life Sciences, a biopharmaceutical company, has received four product patents for its new chemical entities (NCEs). These patents represent the NCEs for the treatment of disorders associated with neurodegenerative diseases. The ...
US-based biopharmaceutical company H3 Biomedicine and China-based BGI have entered into collaboration to sequence and publish genomic data from pre-clinical cancer models. The research will focus on identifying and validating recurrent ...
Tags: Biomedicine, biopharmaceutical company, biopharmaceutical
Spanish biopharmaceutical company PharmaMar has selected Medidata Solutions' Medidata Clinical Cloud platform to accelerate clinical trials for marine-based oncology drugs. A member of the Zeltia Group and a developer of antitumor drugs ...
Synta Pharmaceuticals, a US-based biopharmaceutical company, has named Dr Sumant Ramachandra as the new president of research and development (R&D). Dr Ramachandra served as senior vice president, R&D, regulatory and medical affairs, and ...
Tags: Synta Pharma, biopharmaceutical company, biopharmaceutical
Shire, a specialty biopharmaceutical company, has acquired Premacure, a privately held Swedish biotechnology company. Premacure is currently developing a protein replacement therapy to treat retinopathy of prematurity (ROP), a rare and ...
Tags: biotechnology company, biopharmaceutical company, biopharmaceutical
Immunobiology (ImmBio), a UK-based biopharmaceutical company, has bagged £0.2m in funding from the UK government-backed Biomedical Catalyst (BBC) for the pre-clinical development of pneumococcal vaccine PnuBioVax. The pharma company ...
Biopharmaceutical company Pfizer has decided to discontinue the development of filibuvir, an experimental hepatitis C drug, following a strategic review and capital allocation. The drug, which is in mid-stage clinical testing, is facing ...
Tags: Pfizer, filibuvir drug, drug